Cargando…
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
BACKGROUND: Exposure–response analyses were conducted to explore the relationship between selected efficacy and safety endpoints and serum phosphate (PO4) concentrations, a potential biomarker of efficacy and safety, in locally advanced or metastatic urothelial carcinoma patients with FGFR alteratio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807442/ https://www.ncbi.nlm.nih.gov/pubmed/34977972 http://dx.doi.org/10.1007/s00280-021-04381-4 |